Intero Biosystems Inc. is pioneering the future of preclinical testing with our cutting-edge mini-organ platform. We create functional human stem-cell-derived organoids that have the ability to mimic how a human organ would respond to drug candidates in the laboratory setting. Our platform allows customers to mitigate risk and reduce clinical trial costs by identifying safer, more effective medications before moving into humans.